Event
Axxam at Keystone Symposia SLC 2026 | KCC2 Drug Discovery Talk & Poster
Date: 13-16 April 2026
Location: Beverly, MA, USA
Giovanna Maresca,
Team Leader, Cell Biology 2
Assay Development
Meet Axxam at Keystone Symposia SLC 2026
Advancing KCC2 Pharmacological Potentiation for CNS Drug Discovery
Axxam will participate in Keystone Symposia: Solute Carrier Transporters – Structure, Physiology and Pharmacology, taking place April 13–16, 2026 at the Wylie Center and Tupper Manor at Endicott College in Beverly, Massachusetts.
At the meeting, Axxam will present both a talk and a poster entitled:
- Advancing KCC2 Pharmacological Potentiation: Breaking the State-of-the-Art for CNS Drug Discovery
Our contribution will be featured within the session:
- Emerging SLC Technologies for Drug Discovery
Thursday, April 16, 2026
🕚8:00–11:00 AM
📍Beverly Room
Our contribution at the conference
KCC2 is an important transporter in the central nervous system and a highly relevant target in the search for new therapeutic strategies for neurological disorders.
At Keystone Symposia SLC 2026, Axxam will highlight its work on KCC2 pharmacological potentiation, presenting an approach designed to support the discovery of novel modulators for challenging CNS targets.
This contribution reflects Axxam’s broader expertise in:
- assay development for complex membrane proteins
- screening strategies for difficult targets
- CNS-focused drug discovery support
Why this matters
Solute carrier transporters are increasingly recognized as important targets in drug discovery, yet many remain difficult to study and pharmacologically modulate.
KCC2 is a compelling example of this challenge in CNS research, where robust discovery platforms and fit-for-purpose pharmacological approaches are essential to move programs forward.
By presenting this work at Keystone Symposia, Axxam aims to contribute to the discussion around emerging technologies for transporter drug discovery and their application to complex neurological targets.
Meet us at the Conference
If you are attending the meeting and are interested in CNS drug discovery, transporter biology, or screening approaches for complex targets, we would be pleased to connect.